ESG Report

Overview

The report presents NextPharma's 2024 sustainability strategy across environmental, social, and governance priorities. It reports a 26% reduction in Scope 1 and 2 emissions since 2021 and states that the company formalized its SBTi commitment, targeting absolute reductions of 42% in Scope 1 and 2 and 25% in Scope 3 by 2030. The report also records no fatal accidents across the NextPharma Group in 2024.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

SBTi status

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services